Acute rheumatic fever and poststreptococcal reactive arthritis reconsidered

Current Opinion in Rheumatology

Volumn 22, Issue 4, 2010, Pages 437-442

  Van Der Helm Van Mil, Annette Hm ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLIC ACID DERIVATIVE;

AGE; AUTOIMMUNITY; BACTERIAL IMMUNITY; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CARDIOVASCULAR RISK; CARDITIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG RESPONSE; GROUP A STREPTOCOCCAL INFECTION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SERODIAGNOSIS; VALVULAR HEART DISEASE;

ARTHRITIS, REACTIVE; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENCE; PREVALENCE; RHEUMATIC FEVER; STREPTOCOCCAL INFECTIONS;

EID: 77953471267     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328337ba26     Document Type: Review

References (32)

1. Tibazarwa KB, Volmink JA, Mayosi BM. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 2008; 94:1534-1540.
2. Hochberg Rheumatology. 3rd edition. 2003; 1131-1141.
3. World Health Organisation Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation. Geneve WHO, Oct to 1 Nov 2001. WHO Tech Rep Ser 2001; 923.
4. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocar ditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009; 119:1541-1551.
5. Li EK. Rheumatic disorders associated with streptococcal infections. Bail-lieres Best Pract Res Clin Rheumatol 2000; 14:559-578.
6. Ahmed S, Ayoub EM, Scornik JC, et al. Poststreptococcal reactive arthritis: clinical characteristics and association with HLA-DR alleles. Arthritis Rheum 1998; 41:1096-1102.
7. Ahmed S, Ayoub EM. Poststreptococcal reactive arthritis. Pediatr Infect Dis J 2001; 20:1081-1082.
8. Mackie SL, Keat A. Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxford) 2004; 43:949-954.
9. Deighton C. Beta haemolytic streptococci and reactive arthritis in adults. Ann Rheum Dis 1993; 52:475-482. (Pubitemid 23209609)
10. Jansen TL, Janssen M, de Jong AJ, Jeurissen ME. Poststreptococcal reactive arthritis: a clinical and serological description, revealing its distinction from acute rheumatic fever. J Intern Med 1999; 245:261-267.
11. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005; 366:155-168.
12. Tutar E, Atalay S, Yilmaz E, et al. Poststreptococcal reactive arthritis in children: is it really a different entity from rheumatic fever? Rheumatol Int 2002; 22:80-83.
13. De Cunto CL, Giannini EH, Fink CW, et al. Prognosis of children with poststreptococcal reactive arthritis. Pediatr Infect Dis J 1988; 7:683-686.
14. Al-Wahadneh AM, Khriesat IA-A-H. Poststreptococcal reactive arthritis (PSRA): clinical features and risk of carditis. Kuwait Med J. 2005. 37. 82-85.
15. Aviles RJ, Ramakrishna G, Mohr DN, et al. Poststreptococcal reactive arthritis in adults: a case series. Mayo Clin Proc 2000; 75:144-147.
16. Gutierrez-Urena S, Molina J, Molina JF, et al. Poststreptococcal reactive arthritis, clinical course, and outcome in 6 adult patients. J Rheumatol 1995; 22:1710-1713.
17. van Bemmel JM, Delgado V, Holman ER, et al. No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis. Arthritis Rheum 2009; 60:987-993.
18. Jansen TL, Janssen M, Macfarlane JD, de Jong AJ. Poststreptococcal reactive myalgia: a novel syndrome secondary to infection with group A or G streptococci. Br J Rheumatol 1998; 37:1343-1348.
19. Currie BJ. Group A streptococcal infections of the skin: molecular advances but limited therapeutic progress. Curr Opin Infect Dis 2006; 19:1 32-138.
20. Denbow CE, Bartonm EN, Smikle MF. The prophylaxis of acute rheumatic fever in a pair of monozygotic twins: the public health implications. West Indian Med J 1999; 48:242-243.
21. Taranta A, Torosdag S, Metrakos JD, et al. Rheumatic fever in monozygotic and dizygotic twins. Circulation 1959; 20:778-792.
22. Guilherme L, Kalil J. Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol 2009. [Epub ahead of print]
23. Haydardedeoglu FE, Tutkak H, Kose K, Düzgun N. HLA-DR alleles in patients with poststreptococcal reactive arthritis. Rheumatol Int 2006; 27:111-113.
24. Bryant PA, Robins-Browne R, Carapetis JR, Curtis N. Some of the people, some of the time: susceptibility to acute rheumatic fever. Circulation 2009; 119:742-753.
25. Ayoub EM, Ahmed S. Update on complications of group A streptococcal infections. Curr Probl Pediatr 1997; 27:90-101.
26. Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol 2007; 66:199-207.
27. Düzgün N, Duman T, Haydardedeoglu FE, Tutkak H. Cytotoxic T lymphocyte-associated antigen-4 polymorphism in patients with rheumatic heart disease. Tissue Antigens 2009; 74:539-542.
28. Guilherme L, Kalil J, Cunningham M. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 2006; 39:31-39. (Pubitemid 43878518)
29. Ellis NM, Li Y, Hildebrand W, et al. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol 2005; 175:5448-5456.
30. Baird RW, Bronze MS, Kraus W, et al. Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium. J Immunol 1991; 146:3132-3137.
31. No authors listed. Guidelines for the diagnosis of rheumatic fever, Jones criteria, 1992 update. Special writing group of the committee on rheumatic fever, and Kawasaki disease of the council on cardiovascular disease in the young of the American Heart Association. JAMA 1992; 268:2069-2073.
32. Barash J, Mashiach E, Navon-Elkan P, et al. Differentiation of poststreptococcal reactive arthritis from acute rheumatic fever. J Pediatr 2008; 153:696-699.